Ratio Therapeutics
Ratio Therapeutics’ Trillium targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets.
$20M
Latest Funding
Series A
Latest Funding Stage
2023-02-01
Funding Date
18
Employees
United States
Location
Boston, Massachusetts
City & State
Key Contacts
Open Positions
View Careers PageHiring For
Similar Startups
EvidenceHunt
EvidenceHunt is an AI-powered research assistant developed by medical professionals for healthcare research. Our focus is on delivering tools that streamline gathering and analyzing clinical evidence. With features like AI Chat for interactive queries and comprehensive Direct Search options, EvidenceHunt allows precise data retrieval andanalysis.
Ignota Labs
Ignota Labs recognizes that safety errors during the drug discovery process can result in expensive setbacks and delays in bringing life-changing medications to market. Ignota Labs world leading AI methods, which include deep learning and machine learning approaches, are intended to examine complicated molecular data and provide accurate toxicitypredictions.
Monument Therapeutics
Monument Therapeutics medical approach utilizes proprietary digital biomarkers to reduce heterogeneity and identify patients with homogenous underlying neurobiology, enabling researchers to focus on the advancement of neuroscience drugs in areas of unmet medical needs.
Stablepharma
Stablepharma’s technology platform, StablevaX™ converts existing approved vaccines, therapeutics and diagnostics into fridge free thermostable products that do not require refrigeration to preserve them, thereby addressing the global challenges of the cold chain. Stablepharma’s R&D team have identified up to 60 vaccine candidates that could be suitable for StablevaX™ technology.